BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15967904)

  • 1. Comparison of the clinical and histological characteristics and survival of distal esophageal-gastroesophageal junction adenocarcinoma in patients with and without barrett mucosa.
    Portale G; Peters JH; Hagen JA; Demeester SR; Gandamihardja TA; Tharavej C; Hsieh CC; Demeester TR
    Arch Surg; 2005 Jun; 140(6):570-4; discussion 574-5. PubMed ID: 15967904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
    Schumpelick V; Dreuw B; Ophoff K; Fass J
    Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barrett's esophagus and adenocarcinoma of the esophagus and gastroesophageal junction.
    Duhaylongsod FG; Wolfe WG
    J Thorac Cardiovasc Surg; 1991 Jul; 102(1):36-41; discussion 41-2. PubMed ID: 2072727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome.
    Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
    Ann Surg; 2007 Jul; 246(1):1-8. PubMed ID: 17592282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy.
    Cardona K; Zhou Q; Gönen M; Shah MA; Strong VE; Brennan MF; Coit DG
    Ann Surg Oncol; 2013 Feb; 20(2):548-54. PubMed ID: 22941159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenocarcinoma in the distal esophagus with and without Barrett esophagus. Differences in symptoms and survival rates.
    Johansson J; Johnsson F; Walther B; Willén R; Staël von Holstein C; Zilling T
    Arch Surg; 1996 Jul; 131(7):708-13. PubMed ID: 8678768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine in Barrett's mucosa and adenocarcinomas of the gastroesophageal junction.
    Koppert LB; Wijnhoven BP; Tilanus HW; Stijnen T; Van Dekken H; Dinjens WN
    Int J Surg Pathol; 2004 Apr; 12(2):117-25. PubMed ID: 15173916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
    Zhang X; Watson DI; Jamieson GG
    Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus.
    Leers JM; DeMeester SR; Chan N; Ayazi S; Oezcelik A; Abate E; Banki F; Lipham JC; Hagen JA; DeMeester TR
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):594-602; discussion 601-2. PubMed ID: 19698841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction.
    Hamilton SR; Smith RR; Cameron JL
    Hum Pathol; 1988 Aug; 19(8):942-8. PubMed ID: 3402983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dichotomy in carcinogenesis of the distal esophagus and esophagogastric junction: intestinal-type vs cardiac-type mucosa-associated adenocarcinoma.
    Demicco EG; Farris AB; Baba Y; Agbor-Etang B; Bergethon K; Mandal R; Daives D; Fukuoka J; Shimizu M; Dias-Santagata D; Ogino S; Iafrate AJ; Gaissert HA; Mino-Kenudson M
    Mod Pathol; 2011 Sep; 24(9):1177-90. PubMed ID: 21572404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of patients with carcinoma of the esophagus treated with combined-modality therapy.
    Wolfe WG; Vaughn AL; Seigler HF; Hathorn JW; Leopold KA; Duhaylongsod FG
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):749-55; discussion 755-6. PubMed ID: 8469009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction.
    Westerterp M; Koppert LB; Buskens CJ; Tilanus HW; ten Kate FJ; Bergman JJ; Siersema PD; van Dekken H; van Lanschot JJ
    Virchows Arch; 2005 May; 446(5):497-504. PubMed ID: 15838647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Barrett's esophagus respond to chemoradiation therapy for adenocarcinoma of the esophagus?
    Barthel JS; Kucera ST; Lin JL; Hoffe SE; Strosberg JR; Ahmed I; Dilling TJ; Stevens CW
    Gastrointest Endosc; 2010 Feb; 71(2):235-40. PubMed ID: 20003971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenocarcinoma of the esophagus with and without Barrett mucosa.
    Sabel MS; Pastore K; Toon H; Smith JL
    Arch Surg; 2000 Jul; 135(7):831-5; discussion 836. PubMed ID: 10896378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenocarcinomas of the distal esophagus and "gastric cardia" are predominantly esophageal carcinomas.
    Chandrasoma P; Wickramasinghe K; Ma Y; DeMeester T
    Am J Surg Pathol; 2007 Apr; 31(4):569-75. PubMed ID: 17414104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.
    Lord RV; Park JM; Wickramasinghe K; DeMeester SR; Oberg S; Salonga D; Singer J; Peters JH; Danenberg KD; Demeester TR; Danenberg PV
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):246-53. PubMed ID: 12579092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic importance of pathologically involved celiac node metastases in node-positive patients with carcinoma of the distal esophagus or gastroesophageal junction: a surgical series from the Mayo Clinic.
    Schomas DA; Quevedo JF; Donahue JM; Nichols FC; Romero Y; Miller RC
    Dis Esophagus; 2010 Apr; 23(3):232-9. PubMed ID: 19515184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualized surgical strategies for cancer of the esophagogastric junction.
    Stein HJ; Feith M; Siewert JR
    Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma.
    Grant KS; DeMeester SR; Kreger V; Oh D; Hagen JA; Chandrasoma P; DeMeester TR
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):31-7. PubMed ID: 23312980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.